8161.HK

MediNet Group Limited [8161.HK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

8161.HK Stock Summary

8161.HK has more than 664 years of cash runway (7978 months)

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 years (Yearly statements)

Does not have any significance market cap ($18.3M)

Profit margins (-0.25%) are lower than the previous year (-0.23%)

Debt-to-Equity ratio of 1.8 is considered moderate, deeper research suggested.

In the News

8161.HK Financial details

Company Rating

Buy

Market Cap

18.3M

Income

-27.11M

Revenue

109.75M

Book val./share

0.23

Cash/share

0.48

Dividend

Dividend %

Employees

Optionable

Shortable

Yes

Earnings

09 Feb 2024

P/E

-0.68

Forward P/E

PEG

-0.02

P/S

0.17

P/B

1.96

P/C

0.92

P/FCF

Quick Ratio

0.54

Current Ratio

0.87

Debt / Equity

1.8

LT Debt / Equity

0.3

EPS (TTM)

-0.65

EPS next Y

EPS next Q

EPS this Y

300%

EPS next Y

EPS next 5Y

EPS last 5Y

13.4%

Revenue last 5Y

-4.75%

Revenue Q/Q

-0.59%

EPS Q/Q

36.36%

SMA20

-4.35%

SMA50

41.94%

SMA100

Inst Own

Inst Trans

ROA

-56%

ROE

-512%

ROC

-2.27%

Gross Margin

49%

Oper. Margin

-25%

Profit Margin

-25%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

0.25-0.63

52W High

52W Low

RSI

53.98

Rel Volume

Avg Volume

873

Volume

Perf Week

-1.12%

Perf Month

10%

Perf Quarter

Perf Half Y

76%

Beta

0.812

Volatility

0%, 0.02%

Prev Close

Price

0.44

Change

8161.HK Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	3.39	3.48	3.11	2.91	2.65
Net income per share	-0.32	-0.36	0.11	-0.15	-0.6
Operating cash flow per share	-0.07	0.12	0.45	0.17	0.25
Free cash flow per share	-0.16	0.06	0.4	0.16	0.23
Cash per share	0.66	0.38	0.5	0.38	0.37
Book value per share	1.28	0.92	1.03	0.88	0.28
Tangible book value per share	0.66	0.34	0.49	0.37	0.18
Share holders equity per share	1.28	0.92	1.03	0.88	0.28
Interest debt per share	-0.34	0.3	0.36	0.32	0.25
Market cap	72.8M	58.24M	67.81M	45.76M	12.48M
Enterprise value	45.31M	54.19M	61.4M	43.01M	6.73M
P/E ratio	-5.42	-3.9	14.26	-7.36	-0.5
Price to sales ratio	0.52	0.4	0.52	0.38	0.11
POCF ratio	-25.81	12.11	3.65	6.34	1.2
PFCF ratio	-11.13	23.57	4.1	7.09	1.29
P/B Ratio	1.37	1.52	1.58	1.24	1.06
PTB ratio	1.37	1.52	1.58	1.24	1.06
EV to sales	0.32	0.37	0.47	0.36	0.06
Enterprise value over EBITDA	3.19	5.39	3.12	5.8	-0.59
EV to operating cash flow	-16.06	11.27	3.3	5.95	0.65
EV to free cash flow	-6.93	21.93	3.71	6.67	0.7
Earnings yield	-0.18	-0.26	0.07	-0.14	-1.99
Free cash flow yield	-0.09	0.04	0.24	0.14	0.77
Debt to equity	-0.27	0.31	0.33	0.35	0.84
Debt to assets	-0.17	0.16	0.19	0.19	0.23
Net debt to EBITDA	-1.93	-0.4	-0.33	-0.37	0.51
Current ratio	1.32	1.06	1.17	1.03	0.91
Interest coverage	0	-8.2	0.64	-10.9	-18.78
Income quality	0.23	-0.34	3.92	-1.07	-0.41
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.3	0.33	0.3	0.31	0.04
Capex to operating cash flow	1.32	-0.49	-0.11	-0.11	-0.07
Capex to revenue	-0.03	-0.02	-0.02	-0.01	-0.01
Capex to depreciation	-0.83	-0.15	-0.14	-0.05	-0.05
Stock based compensation to revenue	0	0	0	0	0
Graham number	3.05	2.73	1.63	1.72	1.95
ROIC	-0.27	-0.1	0.01	-0.11	-0.33
Return on tangible assets	-0.22	-0.31	0.09	-0.13	-0.61
Graham Net	0.08	-0.26	-0.16	-0.23	-0.23
Working capital	10.18M	1.55M	4.39M	844K	-2.4M
Tangible asset value	27.48M	14.04M	20.42M	15.58M	9.42M
Net current asset value	8.93M	-5.64M	-2.44M	-5.2M	-6.26M
Invested capital	-0.27	0.31	0.33	0.35	0.84
Average receivables	5.46M	10.09M	8.12M	7.73M	8.37M
Average payables	9.71M	8.59M	5.8M	5.13M	6.55M
Average inventory	736.5K	920.5K	872K	572.5K	428.5K
Days sales outstanding	28.32	23.29	19.71	25.5	27.38
Days payables outstanding	51.78	31.23	32.96	32.47	55.41
Days of inventory on hand	3.57	5.42	4.04	3.23	2.48
Receivables turnover	12.89	15.67	18.52	14.31	13.33
Payables turnover	7.05	11.69	11.07	11.24	6.59
Inventory turnover	102.36	67.35	90.24	113.07	147.15
ROE	-0.25	-0.39	0.11	-0.17	-2.12
Capex per share	-0.09	-0.06	-0.05	-0.02	-0.02

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q2

Metric	2022-09-30	2022-12-31	2023-03-31	2023-06-30	2023-09-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0.73	0.6	0.65	0.7	0.7
Net income per share	0	-0.12	-0.48	-0.02	-0.03
Operating cash flow per share	0.21	0	0.04	0	0.02
Free cash flow per share	0.2	0	0.04	0	-0.01
Cash per share	0.48	0.48	0.37	0.37	0.48
Book value per share	0.89	0.89	0.28	0.27	0.23
Tangible book value per share	0.4	0	0.18	0	0.12
Share holders equity per share	0.89	0.89	0.28	0.27	0.23
Interest debt per share	0.3	0	0.24	0	0.41
Market cap	16.02M	14.14M	12.48M	16.43M	11.02M
Enterprise value	8.3M	34.12M	6.73M	32.01M	8.04M
P/E ratio	-26.69	-0.7	-0.16	-4.28	-2.1
Price to sales ratio	0.53	0.57	0.46	0.56	0.38
POCF ratio	1.82	0	8.04	0	15.57
PFCF ratio	1.97	0	8.11	0	-17.75
P/B Ratio	0.43	0.38	1.06	1.45	1.17
PTB ratio	0.43	0.38	1.06	1.45	1.17
EV to sales	0.27	1.38	0.25	1.1	0.28
Enterprise value over EBITDA	2.47	-19.75	-0.4	20.58	9
EV to operating cash flow	0.94	0	4.33	0	11.36
EV to free cash flow	1.02	0	4.37	0	-12.95
Earnings yield	-0.01	-0.35	-1.59	-0.06	-0.12
Free cash flow yield	0.51	0	0.12	0	-0.06
Debt to equity	0.33	0	0.84	0	1.8
Debt to assets	0.18	0	0.23	0	0.35
Net debt to EBITDA	-2.3	-11.56	0.34	10.02	-3.34
Current ratio	1.08	0	0.91	0	0.87
Interest coverage	-0.63	-39.09	-173.82	-10.88	-6.86
Income quality	-195.96	0	-0.06	0	-0.31
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.29	0	0.04	0	0.04
Capex to operating cash flow	-0.08	0	-0.01	0	-1.88
Capex to revenue	-0.02	0	0	0	-0.05
Capex to depreciation	-0.1	0	0	0	-0.3
Stock based compensation to revenue	0	0	0	0	0
Graham number	0.27	1.55	1.74	0.38	0.4
ROIC	0	-0.14	-0.63	-0.11	-0.03
Return on tangible assets	0	0	-0.48	0	-0.03
Graham Net	-0.17	0.48	-0.23	0.37	-0.29
Working capital	2.27M	19.98M	-2.4M	15.57M	-4.78M
Tangible asset value	16.58M	0	9.42M	0	7.1M
Net current asset value	-3.21M	19.98M	-6.26M	15.57M	-7.77M
Invested capital	0.33	0	0.84	0	1.8
Average receivables	3.76M	3.76M	4.14M	4.14M	5.11M
Average payables	1.4M	1.4M	4.08M	4.08M	5.1M
Average inventory	193K	193K	182.5K	182.5K	263.5K
Days sales outstanding	22.3	0	27.69	0	31.76
Days payables outstanding	18.32	0	55.23	0	60.96
Days of inventory on hand	2.53	0	2.47	0	3.15
Receivables turnover	4.04	0	3.25	0	2.83
Payables turnover	4.91	0	1.63	0	1.48
Inventory turnover	35.58	0	36.4	0	28.57
ROE	0	-0.14	-1.69	-0.08	-0.14
Capex per share	-0.02	0	0	0	-0.03

8161.HK Frequently Asked Questions

What is MediNet Group Limited stock symbol ?

MediNet Group Limited is a HK stock and trading under the symbol 8161.HK

What is MediNet Group Limited stock quote today ?

MediNet Group Limited stock price is $0.44 today.

Is MediNet Group Limited stock public?

Yes, MediNet Group Limited is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Check Those

Similar Market Cap

Company Profile

Volume Average 873
Market Capitalization 18.3M
Employee 89
CEO Mr. Chi Wai Chan
Headquarters Causeway Bay,HK
IPO Date 2016-05-31
Website https://www.medinetgroup.com

MediNet Group Limited, an investment holding company, provides medical and dental solutions to corporates, insurance companies, and individuals in Hong Kong and the People's Republic of China. It operates two MediNet Centres that offer a range of medical services, including general practitioner consultation services, immunization services, and men's health medical services, as well as health assessment and body checkup services; six dental clinics, which provide various dental services comprising scaling and polishing, fillings, intra oral X-rays, routine oral examination, oral health education, preventive dental care, and cosmetic dental treatment, as well as teeth restoration, dentures, oral and dental laser implant surgery, orthodontics, veneer, invisalign and implants, and teeth whitening services to plan members and self-paid patients; and a DNA genetic laboratory center. The company also provides various services, including physiotherapy, Chinese medicine practitioner, vaccination, X-ray, and diagnostic laboratory tests; and specialist services that offers professional solutions to various health issues. In addition, it provides online services to sell dental and medical consultation services. The company was founded in 1994 and is headquartered in Causeway Bay, Hong Kong. MediNet Group Limited is a subsidiary of MediNet International Limited.